Protagonist Therapeutics, Inc. (PTGX) NASDAQ
$46.57 0.92 (2.02%)
Market Cap: $2.74B
As of 09/13/24 12:05 PM EDT. Market open.
Protagonist Therapeutics, Inc. (PTGX)
NASDAQ
$46.57
0.92 (2.02%)
Market Cap: $2.74B
As of 09/13/24 12:05 PM EDT. Market open.
Add to Portfolio
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with polycythemia vera and hereditary hemochromatosis, ... read more
COMPANY PROFILE
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Dinesh V. Patel Ph.D.
Full Time Employees
125
CEO Compensation (Base)
$600,000
CEO Compensation (Total)
$5.54M
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Dinesh V. Patel Ph.D.
Full Time Employees
125
CEO Compensation (Base)
$600,000
CEO Compensation (Total)
$5.54M
Address
7707 Gateway Boulevard, CA, Newark, 94560-1160.
PRICE CHART FOR PROTAGONIST THERAPEUTICS, INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$45.49
Previous Close
$45.65
Days Range
$45.42 - $47.10
52 week range
$13.72 - $47.10
Volume
214,340
Avg. Volume (30 days)
951,167
Market Cap
$2.74B
Dividend Yield
-
P/E
17.12
Shares Outstanding
58,904,600
Open
$45.49
Previous Close
$45.65
Days Range
$45.42 - $47.10
52 week range
$13.72 - $47.10
Volume
214,340
Avg. Volume (30 days)
951,167
Market Cap
$2.74B
Dividend Yield
-
P/E
17.12
Shares Outstanding
58,904,600
FINANCIAL STATEMENTS FOR PROTAGONIST THERAPEUTICS, INC.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR PROTAGONIST THERAPEUTICS, INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Waddill William D. | Director | Sep 10, 2024 | Option Exercise | $12.88 | 8,000 | 103,040 | 20,000 | Sep 12, 2024, 07:38 PM |
| Waddill William D. | Director | Sep 10, 2024 | Sale | $45.00 | 8,000 | 360,000 | 12,000 | Sep 12, 2024, 07:38 PM |
| Waddill William D. | Director | Jul 24, 2024 | Option Exercise | $12.88 | 8,000 | 103,040 | 20,000 | Jul 26, 2024, 04:31 PM |
| Waddill William D. | Director | Jul 24, 2024 | Sale | $40.00 | 8,000 | 320,000 | 12,000 | Jul 26, 2024, 04:31 PM |
| Waddill William D. | Director | Jun 07, 2024 | Option Exercise | $12.88 | 8,000 | 103,040 | 20,000 | Jun 11, 2024, 04:30 PM |
| Waddill William D. | Director | Jun 07, 2024 | Sale | $35.00 | 8,000 | 280,000 | 12,000 | Jun 11, 2024, 04:30 PM |
| PATEL DINESH V PH D | President and CEO | Jun 07, 2024 | Sale | $35.19 | 35,000 | 1,231,650 | 515,415 | Jun 11, 2024, 04:30 PM |
| Ali Asif | Chief Financial Officer | Apr 18, 2024 | Sale | $25.11 | 1,234 | 30,986 | 37,163 | Apr 19, 2024, 08:05 PM |
| PATEL DINESH V PH D | President and CEO | Apr 01, 2024 | Sale | $28.31 | 25,000 | 707,750 | 549,590 | Apr 02, 2024, 08:29 PM |
| SELICK HAROLD E | Director | Mar 07, 2024 | Option Exercise | $1.89 | 6,490 | 12,266 | 27,996 | Mar 11, 2024, 08:00 PM |
| PATEL DINESH V PH D | President and CEO | Mar 01, 2024 | Sale | $31.62 | 30,000 | 948,600 | 574,590 | Mar 01, 2024, 08:46 PM |
| Waddill William D. | Director | Mar 01, 2024 | Option Exercise | $6.09 | 12,975 | 79,018 | 24,975 | Mar 01, 2024, 08:45 PM |
| Waddill William D. | Director | Mar 01, 2024 | Sale | $31.34 | 12,975 | 406,637 | 12,000 | Mar 01, 2024, 08:45 PM |
| Ali Asif | Chief Financial Officer | Mar 01, 2024 | Option Exercise | $12.17 | 12,000 | 146,040 | 52,645 | Mar 01, 2024, 08:45 PM |
| Ali Asif | Chief Financial Officer | Feb 29, 2024 | Sale | $30.69 | 9,939 | 305,048 | 42,734 | Mar 01, 2024, 08:45 PM |
| Ali Asif | Chief Financial Officer | Mar 01, 2024 | Sale | $32.24 | 14,248 | 459,318 | 40,645 | Mar 01, 2024, 08:45 PM |
| PATEL DINESH V PH D | President and CEO | Feb 26, 2024 | Option Exercise | $29.53 | 10,915 | 322,320 | 604,590 | Feb 28, 2024, 08:02 PM |
| Gupta Suneel | Chief Development Officer | Feb 26, 2024 | Option Exercise | $29.53 | 4,282 | 126,447 | 183,285 | Feb 28, 2024, 08:00 PM |
| PATEL DINESH V PH D | President and CEO | Feb 15, 2024 | Option Exercise | $28.23 | 3,717 | 104,931 | 615,505 | Feb 20, 2024, 08:00 PM |
| MOLINA ARTURO MD | Chief Medical Officer | Jan 16, 2024 | Option Exercise | $24.63 | 427 | 10,517 | 48,350 | Jan 18, 2024, 08:00 PM |
| Ali Asif | Chief Financial Officer | Jan 16, 2024 | Option Exercise | $24.63 | 1,452 | 35,763 | 50,584 | Jan 18, 2024, 08:00 PM |
| Gupta Suneel | Chief Development Officer | Jan 09, 2024 | Option Exercise | $7.38 | 5,000 | 36,900 | 192,567 | Jan 11, 2024, 08:00 PM |
| Gupta Suneel | Chief Development Officer | Jan 09, 2024 | Sale | $25.00 | 5,000 | 125,000 | 187,567 | Jan 11, 2024, 08:00 PM |
| MOLINA ARTURO MD | Chief Medical Officer | Nov 15, 2023 | Sale | $16.24 | 1,848 | 30,012 | 22,527 | Jan 04, 2024, 08:09 PM |
| PATEL DINESH V PH D | President and CEO | Dec 13, 2023 | Sale | $20.08 | 75,000 | 1,506,000 | 534,347 | Dec 15, 2023, 04:30 PM |
| Gupta Suneel | Chief Development Officer | Oct 19, 2023 | Option Exercise | $7.38 | 20,000 | 147,600 | 168,317 | Oct 23, 2023, 04:31 PM |
| PATEL DINESH V PH D | President and CEO | Oct 18, 2023 | Option Exercise | $4.21 | 6,000 | 25,260 | 609,347 | Oct 19, 2023, 04:55 PM |
| Gupta Suneel | Chief Development Officer | May 31, 2023 | Option Exercise | $26.07 | 4,150 | 108,190 | 148,037 | Jun 02, 2023, 07:51 PM |
| PATEL DINESH V PH D | President and CEO | May 31, 2023 | Option Exercise | $26.07 | 12,165 | 317,142 | 602,946 | Jun 02, 2023, 07:50 PM |
| Ali Asif | Chief Financial Officer | May 31, 2023 | Option Exercise | $26.07 | 4,150 | 108,190 | 31,036 | Jun 02, 2023, 07:48 PM |
| Ali Asif | Chief Financial Officer | Apr 18, 2023 | Option Exercise | $23.21 | 1,189 | 27,597 | 23,186 | Apr 19, 2023, 04:28 PM |
| SELICK HAROLD E | Director | Apr 10, 2023 | Option Exercise | $0.87 | 6,196 | 5,391 | 21,506 | Apr 11, 2023, 07:18 PM |
| Liu David Y | Chief R&D Strategy Officer | Nov 16, 2022 | Option Exercise | $2.31 | 100,479 | 231,802 | 167,590 | Nov 17, 2022, 06:24 PM |
| PATEL DINESH V PH D | President and CEO | Aug 23, 2022 | Option Exercise | $4.21 | 20,000 | 84,200 | 604,048 | Aug 24, 2022, 06:15 PM |
| Waddill William D. | Director | May 03, 2022 | Option Exercise | $8.59 | 12,000 | 103,080 | 12,000 | May 04, 2022, 08:41 PM |
| PATEL DINESH V PH D | President and CEO | May 04, 2022 | Option Exercise | $4.21 | 15,742 | 66,274 | 584,048 | May 04, 2022, 08:33 PM |
| Gupta Suneel | Chief Development Officer | Apr 26, 2022 | Option Exercise | $7.38 | 40,000 | 295,200 | 117,561 | Apr 26, 2022, 09:42 PM |
| PATEL DINESH V PH D | President and CEO | Apr 26, 2022 | Option Exercise | $4.21 | 30,000 | 126,300 | 568,306 | Apr 26, 2022, 09:34 PM |
| PATEL DINESH V PH D | President and CEO | Apr 14, 2022 | Option Exercise | $1.89 | 34,087 | 64,424 | 537,847 | Apr 14, 2022, 08:09 PM |
| Gupta Suneel | Chief Development Officer | Feb 28, 2022 | Option Exercise | $24.28 | 649 | 15,758 | 77,007 | Mar 02, 2022, 08:40 PM |
| PATEL DINESH V PH D | President and CEO | Feb 28, 2022 | Option Exercise | $24.28 | 4,648 | 112,853 | 503,760 | Mar 02, 2022, 08:39 PM |
| Liu David Y | Chief Scientific Officer | Feb 28, 2022 | Option Exercise | $24.28 | 2,119 | 51,449 | 66,538 | Mar 02, 2022, 08:38 PM |
| PATEL DINESH V PH D | President and CEO | Dec 21, 2021 | Sale | $32.14 | 15,000 | 482,170 | 477,158 | Dec 23, 2021, 04:17 PM |
| PATEL DINESH V PH D | President and CEO | Sep 21, 2021 | Option Exercise | $4.21 | 40,000 | 168,400 | 492,158 | Sep 21, 2021, 09:45 PM |
| Liu David Y | Chief Scientific Officer | Aug 17, 2021 | Option Exercise | $0.87 | 10,000 | 8,700 | 73,033 | Aug 19, 2021, 05:49 PM |
| Liu David Y | Chief Scientific Officer | Aug 17, 2021 | Sale | $47.56 | 14,779 | 702,889 | 58,254 | Aug 19, 2021, 05:49 PM |
| Noonberg Sarah B. | Director | Feb 11, 2021 | Option Exercise | $6.98 | 3,700 | 25,826 | 3,700 | Feb 12, 2021, 06:36 PM |
| Noonberg Sarah B. | Director | Feb 10, 2021 | Option Exercise | $6.98 | 4,700 | 32,806 | 4,700 | Feb 12, 2021, 06:36 PM |
| Noonberg Sarah B. | Director | Feb 11, 2021 | Sale | $25.09 | 3,700 | 92,833 | 0 | Feb 12, 2021, 06:36 PM |
| Noonberg Sarah B. | Director | Feb 10, 2021 | Sale | $25.47 | 4,700 | 119,722 | 400 | Feb 12, 2021, 06:36 PM |
| PATEL DINESH V PH D | President and CEO | Jan 19, 2021 | Option Exercise | $4.21 | 13,000 | 54,730 | 450,990 | Jan 20, 2021, 08:20 PM |
| PATEL DINESH V PH D | President and CEO | Jan 19, 2021 | Sale | $24.60 | 24,846 | 611,105 | 426,144 | Jan 20, 2021, 08:20 PM |
| KHOSLA CHAITAN PHD | Director | Aug 11, 2020 | Option Exercise | $1.89 | 2,499 | 4,723 | 2,499 | Aug 12, 2020, 05:38 PM |
| KHOSLA CHAITAN PHD | Director | Aug 11, 2020 | Sale | $17.19 | 2,499 | 42,952 | 0 | Aug 12, 2020, 05:38 PM |
| PATEL DINESH V PH D | President and CEO | Mar 20, 2020 | Option Exercise | $1.89 | 10,000 | 18,900 | 439,990 | Mar 23, 2020, 06:14 PM |
| PATEL DINESH V PH D | President and CEO | Mar 12, 2020 | Option Exercise | $1.16 | 18,344 | 21,279 | 429,990 | Mar 13, 2020, 01:04 PM |
| SELICK HAROLD E | Director | Mar 12, 2020 | Buy | $6.70 | 12,000 | 80,400 | 15,310 | Mar 12, 2020, 07:26 PM |
| Giraudo Bryan | Director | Dec 03, 2019 | Buy | $5.70 | 8,000 | 45,620 | 8,000 | Dec 03, 2019, 06:46 PM |
| Gupta Suneel | EVP Clinical Operations | Dec 03, 2019 | Buy | $5.13 | 30,000 | 153,900 | 49,500 | Dec 03, 2019, 06:32 PM |
| Kalkofen Donald A. | Chief Financial Officer | Dec 03, 2019 | Buy | $5.10 | 1,175 | 5,987 | 1,175 | Dec 03, 2019, 06:11 PM |
| PATEL DINESH V PH D | President and CEO | Dec 03, 2019 | Buy | $5.62 | 30,000 | 168,500 | 409,824 | Dec 03, 2019, 06:10 PM |
| PATEL DINESH V PH D | President and CEO | Nov 26, 2019 | Option Exercise | $1.16 | 4,000 | 4,640 | 379,824 | Nov 27, 2019, 02:58 PM |
| Liu David Y | Chief Scientific Officer | Aug 06, 2019 | Sale | $8.85 | 3,395 | 30,044 | 49,802 | Aug 08, 2019, 06:17 PM |
| PATEL DINESH V PH D | President and CEO | Aug 06, 2019 | Sale | $8.85 | 10,792 | 95,535 | 374,792 | Aug 08, 2019, 06:15 PM |
| SELICK HAROLD E | Director | Apr 01, 2019 | Option Exercise | $1.31 | 3,310 | 4,336 | 3,310 | Apr 02, 2019, 07:19 PM |
| Liu David Y | Chief Scientific Officer | Mar 01, 2019 | Sale | $8.03 | 810 | 6,504 | 51,197 | Mar 04, 2019, 06:35 PM |
| PATEL DINESH V PH D | President and CEO | Mar 01, 2019 | Sale | $8.03 | 2,183 | 17,529 | 383,831 | Mar 04, 2019, 06:33 PM |
| Shames Richard S. | Chief Medical Officer | Mar 01, 2019 | Sale | $8.03 | 657 | 5,276 | 32,021 | Mar 04, 2019, 06:29 PM |
| PATEL DINESH V PH D | President and CEO | Feb 06, 2019 | Sale | $7.74 | 10,909 | 84,410 | 367,396 | Feb 08, 2019, 05:37 PM |
| Liu David Y | Chief Scientific Officer | Feb 06, 2019 | Sale | $7.74 | 3,821 | 29,562 | 37,007 | Feb 08, 2019, 05:30 PM |
| Shames Richard S. | Chief Medical Officer | Feb 06, 2019 | Sale | $7.74 | 2,778 | 21,506 | 26,758 | Feb 08, 2019, 05:27 PM |
| PATEL DINESH V PH D | President and CEO | Jan 11, 2019 | Option Exercise | $1.16 | 22,344 | 25,919 | 368,173 | Jan 14, 2019, 07:00 PM |
| CANAAN X L.P. | 10% Owner | May 17, 2018 | Sale | $6.09 | 38,968 | 237,358 | 2,116,552 | May 21, 2018, 04:34 PM |
| Giraudo Bryan | Director | May 16, 2017 | Buy | $6.46 | 10,000 | 64,566 | 10,000 | May 17, 2018, 05:48 PM |
| CANAAN X L.P. | 10% Owner | May 16, 2018 | Sale | $6.46 | 29,441 | 190,071 | 2,155,520 | May 16, 2018, 05:16 PM |
| CANAAN X L.P. | 10% Owner | May 15, 2018 | Sale | $6.48 | 57,715 | 374,080 | 2,184,961 | May 16, 2018, 05:16 PM |
| CANAAN X L.P. | 10% Owner | May 14, 2018 | Sale | $6.37 | 77,591 | 494,224 | 2,242,676 | May 16, 2018, 05:16 PM |
| PATEL DINESH V PH D | President and CEO | May 10, 2018 | Option Exercise | $1.16 | 13,516 | 15,679 | 265,779 | May 11, 2018, 06:50 PM |
| PATEL DINESH V PH D | President and CEO | Apr 02, 2018 | Option Exercise | $1.16 | 20,000 | 23,200 | 252,263 | Apr 03, 2018, 05:17 PM |
| PATEL DINESH V PH D | President and CEO | Mar 26, 2018 | Option Exercise | $0.87 | 11,298 | 9,829 | 232,263 | Mar 28, 2018, 05:20 PM |
| CANAAN X L.P. | 10% Owner | Mar 23, 2018 | Sale | $20.71 | 59,950 | 1,241,325 | 2,320,267 | Mar 26, 2018, 04:25 PM |
| CANAAN X L.P. | 10% Owner | Mar 22, 2018 | Sale | $20.62 | 4,759 | 98,133 | 2,380,217 | Mar 22, 2018, 05:33 PM |
| CANAAN X L.P. | 10% Owner | Mar 21, 2018 | Sale | $20.61 | 17,699 | 364,727 | 2,384,976 | Mar 22, 2018, 05:33 PM |
| CANAAN X L.P. | 10% Owner | Mar 20, 2018 | Sale | $20.61 | 17,060 | 351,538 | 2,402,675 | Mar 22, 2018, 05:33 PM |
| CANAAN X L.P. | 10% Owner | Mar 16, 2018 | Sale | $20.51 | 6,926 | 142,063 | 2,433,174 | Mar 19, 2018, 05:22 PM |
| CANAAN X L.P. | 10% Owner | Mar 19, 2018 | Sale | $20.57 | 13,439 | 276,446 | 2,419,735 | Mar 19, 2018, 05:22 PM |
| CANAAN X L.P. | 10% Owner | Mar 15, 2018 | Sale | $20.64 | 11,751 | 242,521 | 2,440,100 | Mar 15, 2018, 04:55 PM |
| CANAAN X L.P. | 10% Owner | Mar 14, 2018 | Sale | $20.77 | 200 | 4,154 | 2,451,851 | Mar 15, 2018, 04:55 PM |
| CANAAN X L.P. | 10% Owner | Mar 13, 2018 | Sale | $20.84 | 1,204 | 25,094 | 2,452,051 | Mar 15, 2018, 04:55 PM |
| Liu David Y | Chief Scientific Officer | Mar 12, 2018 | Option Exercise | $4.21 | 3,500 | 14,735 | 18,528 | Mar 13, 2018, 04:48 PM |
| Liu David Y | Chief Scientific Officer | Mar 12, 2018 | Sale | $21.29 | 3,500 | 74,500 | 15,028 | Mar 13, 2018, 04:48 PM |
| Liu David Y | Chief Scientific Officer | Mar 02, 2018 | Option Exercise | $1.89 | 875 | 1,654 | 14,197 | Mar 02, 2018, 07:17 PM |
| Liu David Y | Chief Scientific Officer | Mar 02, 2018 | Sale | $20.00 | 875 | 17,500 | 13,322 | Mar 02, 2018, 07:17 PM |
| Liu David Y | Chief Scientific Officer | Jan 16, 2018 | Option Exercise | $1.89 | 875 | 1,654 | 4,697 | Jan 17, 2018, 04:34 PM |
| Liu David Y | Chief Scientific Officer | Jan 16, 2018 | Sale | $20.00 | 875 | 17,500 | 3,822 | Jan 17, 2018, 04:34 PM |
| Shames Richard S. | Chief Medical Officer | Dec 22, 2017 | Option Exercise | $4.21 | 3,529 | 14,857 | 3,529 | Dec 27, 2017, 02:07 PM |
| Shames Richard S. | Chief Medical Officer | Dec 22, 2017 | Sale | $20.50 | 3,529 | 72,345 | 0 | Dec 27, 2017, 02:07 PM |
| PATEL DINESH V PH D | President and CEO | Dec 21, 2017 | Option Exercise | $1.89 | 8,210 | 15,517 | 198,647 | Dec 21, 2017, 07:54 PM |
| PATEL DINESH V PH D | President and CEO | Dec 21, 2017 | Sale | $19.56 | 8,210 | 160,570 | 190,437 | Dec 21, 2017, 07:54 PM |
| PATEL DINESH V PH D | President and CEO | Dec 20, 2017 | Option Exercise | $1.89 | 1,790 | 3,383 | 192,227 | Dec 20, 2017, 09:28 PM |
| PATEL DINESH V PH D | President and CEO | Dec 20, 2017 | Sale | $19.55 | 1,790 | 34,987 | 190,437 | Dec 20, 2017, 09:28 PM |
| Liu David Y | Chief Scientific Officer | Dec 18, 2017 | Option Exercise | $1.89 | 875 | 1,654 | 4,697 | Dec 20, 2017, 09:13 PM |
| Liu David Y | Chief Scientific Officer | Dec 18, 2017 | Sale | $20.00 | 875 | 17,500 | 3,822 | Dec 20, 2017, 09:13 PM |
| O'Neil Thomas P. | Chief Financial Officer | Dec 18, 2017 | Option Exercise | $2.69 | 8,000 | 21,480 | 8,000 | Dec 20, 2017, 09:08 PM |
| O'Neil Thomas P. | Chief Financial Officer | Dec 18, 2017 | Sale | $20.00 | 8,000 | 160,000 | 0 | Dec 20, 2017, 09:08 PM |
| Liu David Y | Chief Scientific Officer | Nov 30, 2017 | Option Exercise | $1.89 | 875 | 1,654 | 4,697 | Dec 01, 2017, 06:56 PM |
| Liu David Y | Chief Scientific Officer | Nov 30, 2017 | Sale | $20.00 | 875 | 17,500 | 3,822 | Dec 01, 2017, 06:56 PM |
| Liu David Y | Chief Scientific Officer | Nov 13, 2017 | Option Exercise | $3.05 | 7,000 | 21,350 | 7,322 | Nov 15, 2017, 07:14 PM |
| Liu David Y | Chief Scientific Officer | Nov 13, 2017 | Sale | $16.97 | 7,000 | 118,761 | 3,822 | Nov 15, 2017, 07:14 PM |
| Shames Richard S. | Chief Medical Officer | Oct 05, 2017 | Option Exercise | $4.21 | 2,017 | 8,492 | 2,017 | Oct 10, 2017, 07:04 PM |
| Shames Richard S. | Chief Medical Officer | Oct 05, 2017 | Sale | $19.00 | 2,017 | 38,323 | 0 | Oct 10, 2017, 07:04 PM |
| Shames Richard S. | Chief Medical Officer | Sep 12, 2017 | Sale | $14.31 | 3,687 | 52,753 | 0 | Sep 12, 2017, 07:50 PM |
| Shames Richard S. | Chief Medical Officer | Aug 29, 2017 | Option Exercise | $4.21 | 1,512 | 6,366 | 3,377 | Aug 30, 2017, 07:08 PM |
| Shames Richard S. | Chief Medical Officer | Aug 29, 2017 | Sale | $17.00 | 1,512 | 25,704 | 1,865 | Aug 30, 2017, 07:08 PM |
| Liu David Y | Chief Scientific Officer | Aug 28, 2017 | Option Exercise | $4.21 | 3,500 | 14,735 | 5,500 | Aug 29, 2017, 07:48 PM |
| Liu David Y | Chief Scientific Officer | Aug 28, 2017 | Sale | $15.00 | 3,500 | 52,500 | 2,000 | Aug 29, 2017, 07:48 PM |
| Liu David Y | Chief Scientific Officer | Jul 10, 2017 | Option Exercise | $1.89 | 3,500 | 6,615 | 5,500 | Jul 12, 2017, 05:55 PM |
| Liu David Y | Chief Scientific Officer | Jul 10, 2017 | Sale | $12.68 | 3,500 | 44,380 | 2,000 | Jul 12, 2017, 05:55 PM |
| PATEL DINESH V PH D | President and CEO | May 09, 2017 | Option Exercise | $1.16 | 19,099 | 22,155 | 190,437 | May 10, 2017, 08:44 PM |
| PATEL DINESH V PH D | President and CEO | Apr 06, 2017 | Option Exercise | $1.16 | 20,000 | 23,200 | 171,338 | Apr 07, 2017, 09:24 PM |
| PATEL DINESH V PH D | President and CEO | Mar 10, 2017 | Option Exercise | $0.87 | 16,362 | 14,235 | 151,338 | Mar 13, 2017, 07:24 PM |
| JOHNSON & JOHNSON | 10% Owner | Aug 16, 2016 | Buy | $12.00 | 583,333 | 6,999,996 | 2,449,183 | Aug 18, 2016, 05:11 PM |
| Papanek Julie | Director | Aug 16, 2016 | Buy | $12.00 | 583,333 | 6,999,996 | 2,453,255 | Aug 16, 2016, 06:30 PM |
| CANAAN X L.P. | Director | Aug 16, 2016 | Buy | $12.00 | 583,333 | 6,999,996 | 2,453,255 | Aug 16, 2016, 06:28 PM |
| Shanafelt Armen | Director | Aug 16, 2016 | Buy | $12.00 | 583,333 | 6,999,996 | 2,099,482 | Aug 16, 2016, 06:20 PM |
| LV Management Group, LLC | 10% Owner | Aug 16, 2016 | Buy | $12.00 | 583,333 | 6,999,996 | 2,099,482 | Aug 16, 2016, 06:19 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Waddill William D. | Director | 09/10/2024 | 103,040 |
| Waddill William D. | Director | 09/10/2024 | 360,000 |
| Waddill William D. | Director | 07/24/2024 | 103,040 |
| Waddill William D. | Director | 07/24/2024 | 320,000 |
| Waddill William D. | Director | 06/07/2024 | 103,040 |
| Waddill William D. | Director | 06/07/2024 | 280,000 |
| PATEL DINESH V PH D | President and CEO | 06/07/2024 | 1,231,650 |
| Ali Asif | Chief Financial Officer | 04/18/2024 | 30,986 |
| PATEL DINESH V PH D | President and CEO | 04/01/2024 | 707,750 |
| SELICK HAROLD E | Director | 03/07/2024 | 12,266 |
| PATEL DINESH V PH D | President and CEO | 03/01/2024 | 948,600 |
| Waddill William D. | Director | 03/01/2024 | 79,018 |
| Waddill William D. | Director | 03/01/2024 | 406,637 |
| Ali Asif | Chief Financial Officer | 03/01/2024 | 146,040 |
| Ali Asif | Chief Financial Officer | 02/29/2024 | 305,048 |
| Ali Asif | Chief Financial Officer | 03/01/2024 | 459,318 |
| PATEL DINESH V PH D | President and CEO | 02/26/2024 | 322,320 |
| Gupta Suneel | Chief Development Officer | 02/26/2024 | 126,447 |
| PATEL DINESH V PH D | President and CEO | 02/15/2024 | 104,931 |
| MOLINA ARTURO MD | Chief Medical Officer | 01/16/2024 | 10,517 |
| Ali Asif | Chief Financial Officer | 01/16/2024 | 35,763 |
| Gupta Suneel | Chief Development Officer | 01/09/2024 | 36,900 |
| Gupta Suneel | Chief Development Officer | 01/09/2024 | 125,000 |
| MOLINA ARTURO MD | Chief Medical Officer | 11/15/2023 | 30,012 |
| PATEL DINESH V PH D | President and CEO | 12/13/2023 | 1,506,000 |
| Gupta Suneel | Chief Development Officer | 10/19/2023 | 147,600 |
| PATEL DINESH V PH D | President and CEO | 10/18/2023 | 25,260 |
| Gupta Suneel | Chief Development Officer | 05/31/2023 | 108,190 |
| PATEL DINESH V PH D | President and CEO | 05/31/2023 | 317,142 |
| Ali Asif | Chief Financial Officer | 05/31/2023 | 108,190 |
| Ali Asif | Chief Financial Officer | 04/18/2023 | 27,597 |
| SELICK HAROLD E | Director | 04/10/2023 | 5,391 |
| Liu David Y | Chief R&D Strategy Officer | 11/16/2022 | 231,802 |
| PATEL DINESH V PH D | President and CEO | 08/23/2022 | 84,200 |
| Waddill William D. | Director | 05/03/2022 | 103,080 |
| PATEL DINESH V PH D | President and CEO | 05/04/2022 | 66,274 |
| Gupta Suneel | Chief Development Officer | 04/26/2022 | 295,200 |
| PATEL DINESH V PH D | President and CEO | 04/26/2022 | 126,300 |
| PATEL DINESH V PH D | President and CEO | 04/14/2022 | 64,424 |
| Gupta Suneel | Chief Development Officer | 02/28/2022 | 15,758 |
| PATEL DINESH V PH D | President and CEO | 02/28/2022 | 112,853 |
| Liu David Y | Chief Scientific Officer | 02/28/2022 | 51,449 |
| PATEL DINESH V PH D | President and CEO | 12/21/2021 | 482,170 |
| PATEL DINESH V PH D | President and CEO | 09/21/2021 | 168,400 |
| Liu David Y | Chief Scientific Officer | 08/17/2021 | 8,700 |
| Liu David Y | Chief Scientific Officer | 08/17/2021 | 702,889 |
| Noonberg Sarah B. | Director | 02/11/2021 | 25,826 |
| Noonberg Sarah B. | Director | 02/10/2021 | 32,806 |
| Noonberg Sarah B. | Director | 02/11/2021 | 92,833 |
| Noonberg Sarah B. | Director | 02/10/2021 | 119,722 |
| PATEL DINESH V PH D | President and CEO | 01/19/2021 | 54,730 |
| PATEL DINESH V PH D | President and CEO | 01/19/2021 | 611,105 |
| KHOSLA CHAITAN PHD | Director | 08/11/2020 | 4,723 |
| KHOSLA CHAITAN PHD | Director | 08/11/2020 | 42,952 |
| PATEL DINESH V PH D | President and CEO | 03/20/2020 | 18,900 |
| PATEL DINESH V PH D | President and CEO | 03/12/2020 | 21,279 |
| SELICK HAROLD E | Director | 03/12/2020 | 80,400 |
| Giraudo Bryan | Director | 12/03/2019 | 45,620 |
| Gupta Suneel | EVP Clinical Operations | 12/03/2019 | 153,900 |
| Kalkofen Donald A. | Chief Financial Officer | 12/03/2019 | 5,987 |
| PATEL DINESH V PH D | President and CEO | 12/03/2019 | 168,500 |
| PATEL DINESH V PH D | President and CEO | 11/26/2019 | 4,640 |
| Liu David Y | Chief Scientific Officer | 08/06/2019 | 30,044 |
| PATEL DINESH V PH D | President and CEO | 08/06/2019 | 95,535 |
| SELICK HAROLD E | Director | 04/01/2019 | 4,336 |
| Liu David Y | Chief Scientific Officer | 03/01/2019 | 6,504 |
| PATEL DINESH V PH D | President and CEO | 03/01/2019 | 17,529 |
| Shames Richard S. | Chief Medical Officer | 03/01/2019 | 5,276 |
| PATEL DINESH V PH D | President and CEO | 02/06/2019 | 84,410 |
| Liu David Y | Chief Scientific Officer | 02/06/2019 | 29,562 |
| Shames Richard S. | Chief Medical Officer | 02/06/2019 | 21,506 |
| PATEL DINESH V PH D | President and CEO | 01/11/2019 | 25,919 |
| CANAAN X L.P. | 10% Owner | 05/17/2018 | 237,358 |
| Giraudo Bryan | Director | 05/16/2017 | 64,566 |
| CANAAN X L.P. | 10% Owner | 05/16/2018 | 190,071 |
| CANAAN X L.P. | 10% Owner | 05/15/2018 | 374,080 |
| CANAAN X L.P. | 10% Owner | 05/14/2018 | 494,224 |
| PATEL DINESH V PH D | President and CEO | 05/10/2018 | 15,679 |
| PATEL DINESH V PH D | President and CEO | 04/02/2018 | 23,200 |
| PATEL DINESH V PH D | President and CEO | 03/26/2018 | 9,829 |
| CANAAN X L.P. | 10% Owner | 03/23/2018 | 1,241,325 |
| CANAAN X L.P. | 10% Owner | 03/22/2018 | 98,133 |
| CANAAN X L.P. | 10% Owner | 03/21/2018 | 364,727 |
| CANAAN X L.P. | 10% Owner | 03/20/2018 | 351,538 |
| CANAAN X L.P. | 10% Owner | 03/16/2018 | 142,063 |
| CANAAN X L.P. | 10% Owner | 03/19/2018 | 276,446 |
| CANAAN X L.P. | 10% Owner | 03/15/2018 | 242,521 |
| CANAAN X L.P. | 10% Owner | 03/14/2018 | 4,154 |
| CANAAN X L.P. | 10% Owner | 03/13/2018 | 25,094 |
| Liu David Y | Chief Scientific Officer | 03/12/2018 | 14,735 |
| Liu David Y | Chief Scientific Officer | 03/12/2018 | 74,500 |
| Liu David Y | Chief Scientific Officer | 03/02/2018 | 1,654 |
| Liu David Y | Chief Scientific Officer | 03/02/2018 | 17,500 |
| Liu David Y | Chief Scientific Officer | 01/16/2018 | 1,654 |
| Liu David Y | Chief Scientific Officer | 01/16/2018 | 17,500 |
| Shames Richard S. | Chief Medical Officer | 12/22/2017 | 14,857 |
| Shames Richard S. | Chief Medical Officer | 12/22/2017 | 72,345 |
| PATEL DINESH V PH D | President and CEO | 12/21/2017 | 15,517 |
| PATEL DINESH V PH D | President and CEO | 12/21/2017 | 160,570 |
| PATEL DINESH V PH D | President and CEO | 12/20/2017 | 3,383 |
| PATEL DINESH V PH D | President and CEO | 12/20/2017 | 34,987 |
| Liu David Y | Chief Scientific Officer | 12/18/2017 | 1,654 |
| Liu David Y | Chief Scientific Officer | 12/18/2017 | 17,500 |
| O'Neil Thomas P. | Chief Financial Officer | 12/18/2017 | 21,480 |
| O'Neil Thomas P. | Chief Financial Officer | 12/18/2017 | 160,000 |
| Liu David Y | Chief Scientific Officer | 11/30/2017 | 1,654 |
| Liu David Y | Chief Scientific Officer | 11/30/2017 | 17,500 |
| Liu David Y | Chief Scientific Officer | 11/13/2017 | 21,350 |
| Liu David Y | Chief Scientific Officer | 11/13/2017 | 118,761 |
| Shames Richard S. | Chief Medical Officer | 10/05/2017 | 8,492 |
| Shames Richard S. | Chief Medical Officer | 10/05/2017 | 38,323 |
| Shames Richard S. | Chief Medical Officer | 09/12/2017 | 52,753 |
| Shames Richard S. | Chief Medical Officer | 08/29/2017 | 6,366 |
| Shames Richard S. | Chief Medical Officer | 08/29/2017 | 25,704 |
| Liu David Y | Chief Scientific Officer | 08/28/2017 | 14,735 |
| Liu David Y | Chief Scientific Officer | 08/28/2017 | 52,500 |
| Liu David Y | Chief Scientific Officer | 07/10/2017 | 6,615 |
| Liu David Y | Chief Scientific Officer | 07/10/2017 | 44,380 |
| PATEL DINESH V PH D | President and CEO | 05/09/2017 | 22,155 |
| PATEL DINESH V PH D | President and CEO | 04/06/2017 | 23,200 |
| PATEL DINESH V PH D | President and CEO | 03/10/2017 | 14,235 |
| JOHNSON & JOHNSON | 10% Owner | 08/16/2016 | 6,999,996 |
| Papanek Julie | Director | 08/16/2016 | 6,999,996 |
| CANAAN X L.P. | Director | 08/16/2016 | 6,999,996 |
| Shanafelt Armen | Director | 08/16/2016 | 6,999,996 |
| LV Management Group, LLC | 10% Owner | 08/16/2016 | 6,999,996 |
Load More Insider Transactions
FUNDS WITH A POSITION IN PROTAGONIST THERAPEUTICS, INC.
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 5,840,773 | 0.96% | 1.77% | Event Driven, Value |
| BlackRock Inc. | 10,663,695 | 0.00904% | 85.19% | Other |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,001,342 | 0.13% | -9.8% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 1,371,169 | 0.00417% | 5.98% | Other |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 556,835 | 0.19% | -0.66% | Growth |
| CANDRIAM S.C.A. | 273,818 | 0.06% | -23.94% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 297,467 | 0.02% | 813.4% | Other |
| OCONNOR, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS (LLC) | 68,231 | 0.15% | -37.59% | Value |
| AQR CAPITAL MANAGEMENT LLC | 25,055 | 0.00133% | -69.07% | Other |
| BALYASNY ASSET MANAGEMENT L.P. | 57,500 (Put) | 0.00349% | New | Event Driven |
| ALPS ADVISORS INC | 45,772 | 0.01% | 11.37% | Other |
| D. E. SHAW & CO., INC. | 13,152 | 0.00043% | -63.1% | Other |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 30,500 | 0.04% | No change | Growth At A Reasonable Price |
| TUDOR INVESTMENT CORP ET AL | 22,510 | 0.00414% | Exited | Event Driven, Other |
CHANGE IN SHARES OUTSTANDING FOR PROTAGONIST THERAPEUTICS, INC.
STOCK BUYBACKS FOR PROTAGONIST THERAPEUTICS, INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 03/31/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2023
5.24%
1Q
09/30/2023
7.46%
2Q
06/30/2023
12.01%
3Q
03/31/2023
25.75%
4Q
12/31/2022
29.11%
5Q
09/30/2022
29.50%
6Q
06/30/2022
29.65%
7Q
03/31/2022
30.45%
8Q
12/31/2021
32.01%
9Q
09/30/2021
32.53%
10Q
06/30/2021
41.75%
11Q
03/31/2021
43.80%
12Q
12/31/2020
60.42%
13Q
09/30/2020
70.10%
14Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR PROTAGONIST THERAPEUTICS, INC.
LOADING...